FDA gave us a path forward. finally.

Company: Sarepta Therapeutics

Tags: launch, strategy, field

after the ESSENCE miss and months of uncertainty — FDA confirmed we can submit using 9-year data plus real world evidence. they're not pulling the approvals. spent Q4 having really hard conversations. this is the first good news in a while. not guaranteed but having a path matters

13 upvotes · 5 comments